Evaluating pentraxin 3 as a diagnostic biomarker for diabetic retinopathy: a systematic review and meta-analysis
Abstract Background Pentraxin 3 (PTX3), a novel biomarker of vascular inflammation and endothelial dysfunction, has been identified as a potential predictor of diabetic retinopathy (DR). This meta-analysis aimed to assess the association between circulating PTX3 levels and both the presence and seve...
Saved in:
| Main Authors: | Reza Mohammadpour Fard, Negar Sadat Sherafat, Mohammad Rashno, Seyed Sobhan Bahreiny |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-025-01849-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pentraxin-3 as a Biomarker in Diabetes Mellitus: Insights into Inflammation, Vascular Complications, and Modulation by Antidiabetic Medications
by: Roxana-Cristina Dobriceanu, et al.
Published: (2025-04-01) -
The role of the inflammatory protein Pentraxin 3 as a biomarker in patients with ischemic heart disease
by: D. Hristov
Published: (2024-12-01) -
Biomarkers for diabetic retinopathy
by: Maria V. Budzinskaya, et al.
Published: (2020-04-01) -
Advances in understanding the role of pentraxin-3 in lung infections
by: Li Ma, et al.
Published: (2025-04-01) -
Markers of Proliferative Diabetic Retinopathy
by: V. A. Biletskaya, et al.
Published: (2022-10-01)